Survival from rabies encephalitis

被引:42
作者
de Souza, Aaron [1 ]
Madhusudana, Shampur Narayan [2 ]
机构
[1] Goa Med Coll, Dept Neurol, Bambolim 403202, Goa, India
[2] Natl Inst Mental Hlth & Neurosci, Dept Neurovirol, Bangalore 560029, Karnataka, India
关键词
Rabies; Survival; Human rabies immunoglobulin; Purified chick embryo vaccine; REFIT; BLOOD-BRAIN-BARRIER; ANTEMORTEM DIAGNOSIS; VIRUS-INFECTION; NERVOUS-SYSTEM; POSTEXPOSURE PROPHYLAXIS; FAILURE; CLEARANCE; RECOVERY; ANTIBODY; BAT;
D O I
10.1016/j.jns.2014.02.013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Rabies is a major public health problem in Asia and Africa, with nearly 60,000 deaths every year, and represents a substantial economic burden. Neurologists frequently encounter atypical cases, and need to make informed decisions regarding diagnosis and management. No therapy has been shown to unequivocally improve survival in rabies till date. Despite the overwhelmingly fatal nature of this disease, a small number of patients have been reported to survive acute rabies encephalitis with varying degrees of neurological sequelae. This paper presents the eleventh documented case of survival from rabies, which developed after being bitten by a stray dog, albeit with severe neurological residua. Similar to patients in previous reports, this man demonstrated a robust immune response as indicated by peripheral viral clearance and very high serum and cerebrospinal fluid antibody titres. Immunologically-mediated virus clearance therefore appears to be a prerequisite for survival. A detailed review of previously reported survivors, as well as descriptions of the host response and viral clearance in human rabies, current therapy for this disease and future directions in improving the currently dismal prognosis are provided. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:8 / 14
页数:7
相关论文
共 92 条
  • [1] PARTIAL RECOVERY FROM RABIES LN A 9-YEAR-OLD BOY
    ALVAREZ, L
    FAJARDO, R
    LOPEZ, E
    PEDROZA, R
    HEMACHUDHA, T
    KAMOLVARIN, N
    CORTES, G
    BAER, GM
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (12) : 1154 - 1155
  • [2] [Anonymous], 2007, Wkly Epidemiol Rec, V82, P425
  • [3] [Anonymous], 2002, Weekly Epidemiological Records, V77, P109
  • [4] Appolinario CM, 2013, J VIROL ANTIVIR RES, V2, P2, DOI [10.4172/2324-8955.1000111, DOI 10.4172/2324-8955.1000111]
  • [5] USE OF IMMUNOFLUORESCENCE EXAMINATION TO DETECT RABIES VIRUS-ANTIGEN IN THE SKIN OF HUMANS WITH CLINICAL ENCEPHALITIS
    BLENDEN, DC
    CREECH, W
    TORRESANJEL, MJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (04) : 698 - 701
  • [6] Brooks GF, 2001, JAWETZ MELNICK ADELB, P492
  • [7] BUSSEREAU F, 1988, ACTA VIROL, V32, P33
  • [8] SEARCH FOR COMPOUNDS WHICH HAVE AN INHIBITORY EFFECT ON RHABDOVIRUS MULTIPLICATION INVITRO
    BUSSEREAU, F
    CHERMANN, JC
    DECLERCQ, E
    HANNOUN, C
    [J]. ANNALES DE VIROLOGIE, 1983, 134 (01): : 127 - 134
  • [9] RNAi-mediated reversible opening of the blood-brain barrier
    Campbell, Matthew
    Kiang, Anna-Sophia
    Kenna, Paul F.
    Kerskens, Christian
    Blau, Christoph
    O'Dwyer, Laurence
    Tivnan, Amanda
    Kelly, Julie Anne
    Brankin, Brenda
    Farrar, Gwyneth-Jane
    Humphries, Peter
    [J]. JOURNAL OF GENE MEDICINE, 2008, 10 (08) : 930 - 947
  • [10] RABIES VIRUS SELECTIVELY ALTERS 5-HT(1) RECEPTOR SUBTYPES IN RAT-BRAIN
    CECCALDI, PE
    FILLION, MP
    ERMINE, A
    TSIANG, H
    FILLION, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1993, 245 (02): : 129 - 138